Pharmaceutical
| Tue 16 Jun 2026
Taipei, June 16 -- Pasithea Therapeutics Corp has applied Taiwan patent for 10,11-difluoro-12-((2-fluoro-4-iodophenyl)amino)-5,6-dihydroxy-4,5,6,7-tetrahydro-1h-spiro[benzo[b][1,5,4]oxathiazecine-3,1'-cyclopropane] 2,2-dioxide Stereoisomers, and Compositions Comprising and Methods of Using the Same. Lazarus Mathew, Marques Tiago..